Vasoactive intestinal polypeptide pharmaceuticals

Details for Australian Patent Application No. 2005294125 (hide)

Owner Therapei Pharmaceuticals, Inc.

Inventors Nestor, John

Agent Collison & Co

Pub. Number AU-A-2005294125

PCT Pub. Number WO2006/042152

Priority 60/617,500 08.10.04 US

Filing date 7 October 2005

Wipo publication date 20 April 2006

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/042152 Priority application(s): WO2006/042152

18 December 2008 Assignment before Grant

  Therapei Pharmaceuticals, Inc. The application has been assigned to Transition Therapeutics Inc.

8 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005294129-Modulation of replicative fitness by using less frequently used synonymous codons

2005294124-Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels